University at Buffalo - The State University of New York
Skip to Content
Anurag                         Singh

Anurag K. Singh MD

Department of Radiation Oncology

Professor, Director of Radiation Research

Specialty/Research Focus

Radiation Medicine

 

Education and Training:
  • Residency, Radiation Oncology, Washington University in Saint Louis School of Medicine, Mallinckrodt Institute of Radiology (2004)
  • Internship, Internal Medicine, Washington University in Saint Louis School of Medicine, Barnes-Jewish Hospital (2000)
  • MD, Medicine, Washington University in Saint Louis School of Medicine (1999)
  • BS, Molecular Biophysics and Biochemistry, Yale University (1995)
Employment:
  • Professor, Roswell Park Cancer Institute, University at Buffalo (2012-present)
  • Associate Professor, Roswell Park Cancer Institute, University at Buffalo (2007–2012)
  • Attending Physician, Radiation Oncology Branch, National Cancer Institute (2004–2007)
Awards and Honors:
  • Outstanding Accreditation Award from University at Buffalo (2011)
  • Educator of the Year (2009-2010) (2010)
  • CaPSure Mentor (for Nicole SImone) (2006)
  • MENSA Research and Education Scholarship (1995)
  • Magna Cum Laude Graduate (1995)
  • MENSA Research and Education Scholarship (1994)
  • Xerox Technical Merit Scholarship (1994)

Research Expertise:
  • Imaging Cancer: Use of imaging for improved staging and/or delineation of tumors.
  • Novel Radiation Enhancers: Novel agents used in combination with radiation therapy.
  • Radiation Protectors, Quality of Life: Novel Agents
  • Stereotactic Body Radiation Therapy (SBRT): SBRT is a novel method of delivering extremely high radiation doses to very small areas. I have designed, implemented, and run several clinical SBRT trials.
Grants and Sponsored Research:
  • December 2010–December 2015
    A Phase 2 Placebo-Controlled Randomized Study of the Effect of Samital on Incidence, Duration and Severity of Oropharyngeal Mucositis Induced by Chemoradiation for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Indena SPA
    Role: Principal Investigator
    $1,600,478
  • October 2011–September 2014
    Louis Sklarow Memorial Trust
    Louis Sklarow Memorial Trust
    Role: Co-Investigator
    $40,000
  • April 2008–June 2012
    A Phase II Randomized Study of 2 Sterotactic Body Radiation Therapy (SBRT) Regimens for Medically Inoperable Patients with Node Negative, Peripheral Non-Small Cell Lung Cancer
    Roswell Park Alliance Foundation
    Role: Co-Investigator
    $97,963
  • July 2009–December 2011
    Hybrid Imaging Technique (HIT) Guided Biopsy to Map Prostatic Adenocarcinoma in Patients Undergoing Prostatectomy
    Roswell Park Alliance Foundation
    Role: Co-Investigator
    $99,956
  • July 2005–July 2007
    Development of Prostate and Breast Cancer magnetic Resonance Imaging and Image Guided Therapy
    Center for Clinical Research, NCI Intramural Grant
    Role: Principal Investigator
    $280,000
  • April 2012
    Body Warming to Alter (thermo) Regulation and the Microenvironment (B-WARM) Therapy: A Pilot Study
    Braun Foundation
    Role: Principal Investigator
    $75,000
  • September 2007
    MR Imaging to Stratify Prostate Cancer Progression Risk in Patients on Active Surveillance
    Roswell Park Alliance Foundation
    Role: Principal Investigator
    $100,000

Evaluative Studies and Case Reports:
Journal Articles:
  • Singh AK, Suescun JAG, Stephans KL, Bogart JA, Lili T, Malhotra H, Videtic GM, Groman A. A Phase 2 Randomized Study of 2 Stereotactic Body Radiation Therapy Regimens for Medically Inoperable Patients With Node-Negative, Peripheral Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017; 98(1).
  • Platek ME, Jayaprakash V, Gupta V, Cohan DM, Hicks WL, Winslow TB, Platek AJ, Groman A, Dibaj S, Arshad H, Kuriakose MA, Warren GW, Singh AK. Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011. Laryngoscope. 2017; 127(5).
  • Pugh SL, Wyatt G, Wong RK, Sagar SM, Yueh B, Singh AK, Yao M, Nguyen-Tan PF, Yom SS, Cardinale FS, Sultanem K, Hodson DI, Krempl GA, Chavez A, Yeh AM, Bruner DW. Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification. J Pain Symptom Manage. 2017; 53(1).
  • Platek AJ, Jayaprakash V, Merzianu M, Platek ME, Cohan DM, Hicks WL, Marimuthu SP, Winslow TB, Gupta V, Arshad H, Kuriakose MA, Dibaj S, Marshall JR, Reid ME, Warren GW, Singh AK. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation. Laryngoscope. 2016; 126(12).
  • Rivers CI, AlDahlawi I, Wang IZ, Singh AK, Podgorsak MB. The dose penumbra of a custom-made shield used in hemibody skin electron irradiation. J Appl Clin Med Phys. 2016; 17(6).
  • Wyatt G, Pugh SL, Wong RK, Sagar S, Singh AK, Koyfman SA, Nguyen-Tân PF, Yom SS, Cardinale FS, Sultanem K, Hodson I, Krempl GA, Lukaszczyk B, Yeh AM, Berk L. Xerostomia health-related quality of life: NRG oncology RTOG 0537. Qual Life Res. 2016; 25(9).
  • Rich LJ, Winslow TB, Alberico RA, Repasky EA, Seshadri M, Singh AK. Enhanced tumour perfusion following treatment with water-filtered IR-A radiation to the thorax in a patient with head and neck cancer. Int J Hyperthermia. 2016; 32(5).
  • Mix M, Singh AK, Tills M, Dibaj S, Groman A, Jaggernauth W, Rustum Y, Jameson MB. Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck. World J Clin Oncol. 2015; 6(5).
  • Mix M, Ramnath N, Gomez J, de Groot C, Rajan S, Dibaj S, Tan W, Rustum Y, Jameson MB, Singh AK. Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer. World J Clin Oncol. 2015; 6(5).
  • Dobson Amato KA, Hyland A, Reed R, Mahoney MC, Marshall J, Giovino G, Bansal-Travers M, Ochs-Balcom HM, Zevon MA, Cummings KM, Nwogu C, Singh AK, Chen H, Warren GW, Reid M. Tobacco Cessation May Improve Lung Cancer Patient Survival. J Thorac Oncol. 2015; 10(7).
  • Winslow TB, Eranki A, Ullas S, Singh AK, Repasky EA, Sen A. A pilot study of the effects of mild systemic heating on human head and neck tumour xenografts: Analysis of tumour perfusion, interstitial fluid pressure, hypoxia and efficacy of radiation therapy. Int J Hyperthermia. 2015; 31(6).
  • Warren GW, Marshall JR, Cummings KM, Zevon MA, Reed R, Hysert P, Mahoney MC, Hyland AJ, Nwogu C, Demmy T, Dexter E, Kelly M, O'Connor RJ, Houstin T, Jenkins D, Germain P, Singh AK, Epstein J, Dobson Amato KA, Reid ME. Automated tobacco assessment and cessation support for cancer patients. Cancer. 2014; 120(4).
  • Folaron M, Kalmuk J, Lockwood J, Frangou C, Vokes J, Turowski SG, Merzianu M, Rigual NR, Sullivan-Nasca M, Kuriakose MA, Hicks WL, Singh AK, Seshadri M. Vascular priming enhances chemotherapeutic efficacy against head and neck cancer. Oral Oncol. 2013; 49(9).
  • *Platek ME, McCloskey SA, Cruz M, Burke MS, Reid ME, Wilding GE, Rigual NR, Popat SR, Loree TR, Gupta V, Warren GW, Sullivan M, Hicks WL, Singh AK.. Quantification of the Effect of Treatment Duration on Local Regional Failure after Definitive Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy for Squamous Cell Carcinoma of the Head and Neck. Head and Neck. 2013.
  • Sehdev A, Zhao Y, Singh AK, Sharma N. Primary small cell carcinoma of the tonsil: a case report and review of the literature. Case Rep Oncol. 2012; 5(3).
  • Warren GW, Romano M, Kudrimoti MR, Randall ME, McGarry RM, Singh AK, Rangenekar VM. Nicotinic Modulation of Therapeutic Response In Vitro and In Vivo. Int Jn of Cancer. 2012.
  • Martin, K.L, Gomez J, Nazareth, D.P., Warren, G.W., Singh, A.K.,. Quantification of Incidental Mediastinal and Hilar Irradiation Delivered During Definitive Sterotactic Body Radiation Therapy for Peripheral Non-Small Cell Lung Cancer. Medical Dosimetry. 2012.
  • Ko C, Lita E, McNally D, Wood B, Pinto P, Guion P, Smith S, Krieger A, Ning H, Camphausen K, Singh AK, Kaushal A. Early experiences of Image Guided Prostate and Pelvic Nodal Irradiation with Intensity Modulated Radiation Treatment in Localized Prostate Cancer. World J Oncol. 2011.
  • *Krieger A, Iordachita I, Guion P., Singh AK, Kaushal A, Menard C, Pinto P.A., Fichtinger G, Whitcomb L.L.. A MRI-Compatible Robotic System with Hybrid Tracking for MRI-Guided Prostate Intervention. IEEE Trans Biomed Engineering. 2011; 58(11).
  • Sen A, Capitano ML, Spernyak JA, Schueckler JT, Thomas S, Singh AK, Evans SS, Hylander BL, Repasky EA. Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models. Cancer Res. 2011; 71(11).
  • Platek ME, Merzianu M, Mashtare TL, Popat SR, Rigual NR, Warren GW, Singh AK. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol. 2011; 6.
  • Platek ME, Reid ME, Wilding GE, Jaggernauth W, Rigual NR, Hicks WL, Popat SR, Warren GW, Sullivan M, Thorstad WL, Khan MK, Loree TR, Singh AK. Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head Neck. 2011.
  • Singh AK, Mashtare TL, McCloskey SA, Seixas-Mikelus SA, Kim HL, May KS. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis. Int J Radiat Oncol Biol Phys. 2010; 78(4).
  • Schildkraut JS, Prosser N, Savakis A, Gomez J, Nazareth D, Singh AK, Malhotra HK. Level-set segmentation of pulmonary nodules in megavolt electronic portal images using a CT prior. Med Phys. 2010; 37(11).
  • Singh AK, Chen J, Calado R, Sowers A, Mitchell JB, Barrett AJ. TBI with lung dose reduction does not improve hematopoietic cell homing to BM during allogeneic transplantation. Bone Marrow Transplant. 2010; 45(1).
  • Tchabo NE, McCloskey S, Mashtare TL, Andrews C, Singh AK, Mhawech-Fauceglia P, Odunsi K, Lele S, Jaggernauth W. Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006. Gynecol Oncol. 2009; 115(2).
  • *McCloskey S.A., Jaggernauth W., Schwarz J.K., Mashtare T.L., Khan M.K., Hicks W.L., Popat S.R., Rigual N.R., Loree T.R., Singh AK. Radiation Treatment Interruptions Greater than 1 week and Low Hemoglobin Levels (12 gm/dl) are Predictors of Local Regional Failure Following Definitive Concurrent Chemotherapy and IMRT for Squamous Cell Carcinoma of the Head and Neck. American Journal of Clinical Oncology. 2009; 32(6).
  • Simone NL, Singh AK, Cowan JE, Soule BP, Carroll PR, Litwin MS. Pretreatment predictors of death from other causes in men with prostate cancer. J Urol. 2008; 180(6).
  • Xu S, Kruecker J, Turkbey B, Glossop N, Singh AK, Choyke P, Pinto P, Wood BJ. Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies. Comput Aided Surg. 2008; 13(5).
  • Simone NL, Menard C, Soule BP, Albert PS, Guion P, Smith S, Godette D, Crouse NS, Sciuto LC, Cooley-Zgela T, Camphausen K, Coleman CN, Singh AK. Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score. Int J Radiat Oncol Biol Phys. 2008; 70(1).
  • Savani BN, Donohue T, Kozanas E, Shenoy A, Singh AK, Childs RW, Barrett AJ. Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2007; 13(5).
  • Singh AK, Savani BN, Albert PS, Barrett AJ. Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation. Biol Blood Marrow Transplant. 2007; 13(3).
  • Kreucker J, Xu S, Glossop N, Guion P, Choyke P, Singh AK, Wood BJ. Fusion of real-time transrectal ultrasound with pre-acquired MRI for multi-modality prostate imaging. Proc of SPIE. 2007.
  • *Mishra M.V., Singh AK. A Second Transient Prostate-Specific Antigen Elevation Following External Beam Radiation Therapy and Fractionated MRI Guided High Dose Rate Brachytherapy Boost: Case Report and Review of the Literature. Clinical Genitourinary Cancer. 2007; 5(6).
  • Savani, BN, Donohue T, Kozanas E, Shenoy A, Singh AK; Childs, RW, Barrett AJ. Absolute lymphocyte count on day 30 is strongly predictive for outcome after T-cell depleted allogeneic stem cell transplantation for hematological malignancy.. Biol of Blood and Marrow Transplant. 2007; (10).
  • Singh AK, Guion P, Crouse NS, Ullman K, SMith S, Albert PS, Fichtinger G, Choyke PL, Xu S, Kruecker J, Wood BJ, Krieger A, Ning H. Simultaneous Integrated Boost of Biopsy Proven, MRI Defined Dominant Intra-prostatic Lesions to 95 Gray with IMRT: Early Results of a Phase 1 NCI Study. Radiation Oncology. 2007; 2(36).
  • *Soule BP, *Simone NL, Savani B, Ning H, ALbert PS, Barrett AJ, Singh AK. Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant. 2007; 40(6).
  • *Savani BN, Donohur T, Kozanas E, Shenoy A, Singh AK, Childs RW, Barrett AJ. Increased Risk of Bone Loss Without Fracture Risk in Long Term Survivors After Allogeneic Stem Cell Transplantation. Biol. of Blood and Marrow Transplant. 2007; 13(5).
  • *Lattouf JB, Grubb RL, Lee JM, Bjurlin M, ALbert PS, Singh AK, *Ocak I, Choyke P, Coleman J. Yield of MRI Directed Trans-rectal Ultrasound Biopsies of the Prostate in Patients at High Risk of Having Prostate Cancer. BJU Int.. 2007; 99(5).
  • Singh AK, *Savani BN, Albert PS, Barrett AJ. Efficacy of CD34 Positive Stem Cell Dose in Patients Undergoing Allogeneic Peripheral Blood Stem Cell Transplant May Differ with Presence of Lung Dose Reduced Total Body Irradiation. Biol. of Blood and Marrow Transplant. 2007; 13(3).
  • Krieger A, Csoma C, Iordachital II, Guion P, Singh AK, Fichtinger G, Whitcomb LL. Design and preliminary accuracy studies of an MRI-guided transrectal prostate intervention system. Med Image Comput Comput Assist Interv. 2007; 10(Pt 2).
  • Xu S, Kruecker J, Guion P, Glossop N, Neeman Z, Choyke P, Singh AK, Wood BJ. Closed-loop control in TRUS-guided prostate biopsy. Med Image Comput Comput Assist Interv.. 2007; 10(Pt 1).
  • Singh AK, Karimpour SE, *Savani BN, Guion P, *Hope AJ, *Mansueti JR, Ning H, Altemus RM, Wu CO, Barrett AJ. Pretransplant Pulmonary Function Tests Predict Risk of Mortality Following Fractionated Total Body Irradiation and Allogeneic Peripheral Blood Stem Cell Transplant. Int J Radiat Oncol Biol Phys. 2006; 66(2).
  • Singh AK, *Tierney RM, Low DS, *Parikh PJ, Myerson RJ, Deasey JO, *Wu CS, Pereira GC, *Wahab S, Mutic S, Grigsby PW, *Hope AJ. A Prospective Study of differences in duodenum compared to remaining small bowel motion between radiation treatments: Implications for radiation dose escalation in carcinoma of the pancreas. Radiation Oncology. 2006; 1(32).
  • Singh AK, Guion P, Susil RC, Citrin DE, Ning H, Miller RW, Ullman K, Smith S, Crouse NS, Godette DJ, *Stall BR, Coleman CN, Camphausen K, Menard C. Early Observed Transient Prostate-Specific Antigen Elevations On a Pilot Study of External Beam Radiation Therapy and Fractionated MRI Guided High Dose Rate Brachytherapy Boost. Radiation Oncology. 2006; 1(28).
  • Savani BN, Montero A, Srinivasan R, Singh AK, Shenoy A, Mielke S, Rezvani R, Karimpour SE, Childs R, Barrett AJ. Chronic GVHD and pre-transplantation abnormalities pulmonary function are the main determinants worsening pulmonary function in long term survivors after stem cell transplantation. Biol. of Blood and Marrow Transplantation. 2006; (12).
  • *Anders JC, Grigsby PW, Singh AK. Cisplatin Chemotherapy (Without Erythropoietin) and Risk of Life-Threatening Thromboembolic Events in Carcinoma of the Uterine Cervix: The Tip of the Iceberg? A Review of the Literature. Radiation Oncology. 2006; 1(1).
  • Singh AK, Menard C, Guion P, *Simone NL, Smith S, Crouse NS, Godette DJ, Cooley-Zgela T, Sciuto LC, Coleman J, Pinto P, Albert PS, Camphausen K, Coleman CN. Intrarectal Amifostine Suspension May Protect Against Acute Proctitis During Radiation Therapy for Prostate Cancer: A Pilot Study. Int J Radiat Oncol Biol Phys. 2006; 65(4).
  • *Brown MW, Singh AK. Alkaline Phosphatase level increase with initiation of Hormone Therapy For Prostate Cancer Portends Poor Prognosis With Rapid Progression To Bone Metastases: A Case Report and Review of the Literature. Clinical Genitourinary Cancer. 2006; 4(4).
  • Myerson RJ, Singh AK, Bigott H, Englebach J, Kim J, Lamoreaux WT, Moros EG, Novak P, Sharp T, Straube WL, Welch MJ, Xu M. Monitoring the Effect of Mild Hyperthermia on Tumor Hypoxia by Cu-ATSM PET Scanning. Int. J Hyperthermia. 2006; 22.
  • Novák P, Moros EG, Parry JJ, Rogers BE, Myerson RJ, Zeug A, Locke JE, Rossin R, Straube WL, Singh AK. Experience with a small animal hyperthermia ultrasound system (SAHUS): report on 83 tumours. Phys Med Biol. 2005; 50(21).
  • Novak P, Moros EG, Parry JJ, Rogers BE, Myerson RJ, *Zeug A, Locke JE, Rossin R, Welch MJ, Straube WL, Singh AK. Experience with a Small Animal Hyperthermia Ultrasound System (SAHUS): Report on 83 Tumors. Biology, Physics and Medicine. 2005; 50(21).
  • Singh AK. Postoperative Vaginal Brachytherapy Alone is the Treatment of Choice for Grade 1-2, Stage IC Endometrial Cancer. Int J Gyn Cancer. 2005; (15).
  • Locke J, Zeug A, Thompson D Jr, Allan J, Mazzeralla K, Novak P, Hanson D, Singh AK, Moros EG, Pandita TK. Localized versus regional hyperthermia: Comparison of xenotransplants treated with a small ultrasound system and waterbath limb immersion. Int. J. Hyperthermia. 2005; 21(3).
  • Lu W, Parikh PJ, El Naqa I, Nystrom M, Hubenschmidt J, Wahab S, Singh AK, Christensen G, Mutic S, Bradley J, Low D. Quantitation of the four-dimensional computed tomography process. Medical Physics. 2005; 32(4).
  • Singh AK. Results of the 2003 Association of Residents in Radiation Oncology (ARRO)Survey. Int J Radiat Oncol Biol Phys. 2005; 61(3).
  • Singh AK, Grigsby PW, Rader JS, Mutch DG, Powell MA. Cervix Carcinoma, Concurrent Chemoradiation & Salvage of Isolated Para-aortic Lymph Node Recurrence. Int J Radiat Oncol Biol Phys. 2005; 61(2).
  • Low DA, Parikh PJ, El Naqa IM, Nystrom MM, Lu W, Huberschmidt JP, Wahab SH, Mutic S, Singh AK, Christensen G, Bradley JD. Quantitative 4-D CT using a multislice CT scanner. Proc. of the 14th Internaltional Conference on the Use of Computers in Radiation Therapy, Seoul, Korea. 2004.
  • El Naqa IM, Low DA, Christensen G, Parikh PJ, Song JH, Nystrom M, Lu W, Deasey JO, Huberschmidt J, Wahab S, Mutic S, Singh AK, Bradley JD. Medical Imaging 2004: Physiology, Function, and Structure from Medical Images. Proc of SPIE (5369). 2004.
  • Singh AK, Moros EG, Novak P, Straube WE, Locke JE, Zeug A, Myerson RJ. A Micro-PET Compatible, Small Animal Hyperthermia Ultrasound System (SAHUS) for Sustainable, Collimated and Controlled Hyperthermia of Subcutaneously Implanted Tumors. Int. J Hyperthermia. 2004; 20(1).
  • Grigsby PW, Singh AK, Rader JS, Siegel BA, Zoberi IZ. Lymph Node Control in Carcinoma of the Cervix. Int J Radiat Oncol Biol Phys. 2004; 59(3).
  • Singh AK, Lockett MA, Bradley JD. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2003; 55(2).
  • Crane CH, Phan T, Skibber J, Janjan N, Singh AK, Birnbaum EH, Fleshman JW, Kodner IJ, Lockett MA, Picus J, Lin EH, Read TE, Myerson RJ. The Addition of Continuous Infusion 5-FU to Preoperative Radiotherapy Increases Response, Sphincter Preservation, and Overall Survival in Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys. 2003; 57(1).
  • Singh AK, Grigsby PW, Siegel BA, Dehdashti F. FDG-PET Lymph Node Staging and Survival of Patients with FIGO Stage IIIB Cervical Carcinoma. Int J Radiat Oncol Biol Phys. 2003; 56(2).
  • Singh AK, Lockett MA, Bradley JD. Analysis of Clinical and Dosimetric Predictors of Radiation-Induced Esophageal Toxicity in Patients with Non Small Cell Lung Cancer Treated with Three Dimensional Conformal Radiation Therapy. Int J Radiat Oncol Biol Phys. 2001; 55(2).
  • Myerson RJ, Singh AK, Birnbaum E, Fleshman J, Fry R, Kodner I, Lockett M, Picus J, Walz B, Read T. Pre Treatment Clinical Findings Predict Outcome For Patients Receiving Preoperative Radiation For Rectal Cancer. Int J Radiat Oncol Biol Phys. 2001; 50(3).
  • Singh AK, Myerson RJ, Birnbaum EH, Fleshman JW, Kodner IJ, Lockett MA, Read TE. Outcome of patients with rectal adenocarcinoma and localized pelvic non-nodal metastatic foci. Dis Colon Rectum. 2000; 43(9).
  • Singh AK, Myerson RJ, Kodner IJ, Read TA, Fleshman JW, Birnbaum EH. Outcome of Patients with Rectal Adenocarcinoma and Localized Pelvic Non-Nodal Metastatic Foci. Diseases of Colon and Rectum. 2000; 43(9).
See all (58 more)

Presentations:
  • "Lung Cancer Management: Radiation Medicine" RPCI- Lung Cancer 2011 Update, Roswell Park Cancer Institute (2011)
  • "New directions in SBRT: Can we move beyond just peripheral, early stage lung tumors?" Therapists and Dosimetrists Conference, Roswell Park Cancer Institute, Radiation Medicine (2010)
  • "Panel Discussant: Localized and Locally Advanced Lung Cancer" Second Niagara Lung Cancer Symposium, Roswell Park Cancer Institute (2010)
  • "Beyond Perfexion: Extra-cranial SBRT at RPCI" Upstate New York Society for Therapeutic Radiation Oncology (UNYSTRO) Annual Conference, UNYSTRO (2010)
  • "Review of Lung, H&N, and Renal SBRT: Possibilities and Pitfalls" National Cancer Institute Visiting Professor Series, National Cancer Institute, National Cancer Institute (2010)
  • "Improving Radiation Therapy Outcomes, The Biologic Rationale fors: protectors, sensitizers, and SBRT" Therapists and Dosimetrists Conference, Roswell Park Cancer Institute, Radiation Medicine (2009)
  • "Alphabet Soup: IMRT, SBRT and other Advances in Radiation Therapy" Women's Christian Association Hospital, WCA Hospital (2009)
  • "Adjusting radiation therapy to improve outcomes: protectors, sensitizers, and/or mega-doses?" Research Division of the Department of Radiation Oncology, University of Pennsylvania, School of Medicine, Invited Speaker Seminar (2009)
  • "Following prostate cancer, increasing age and treatment modality (irradiation, surgery, surgery and adjuvant radiation) are highly significant predictors of developing bladder cancer, a SEER analysis" ASTRO Annual Meeting, ASTRO (2008)
  • "Hemoglobin, Treatment Time, and Local Failure Following Definitive Concurrent Chemo-IMRT for H&N Cancer" Therapists and Dosimetrists Conf., Roswell Park Cancer Institute, Radiation Medicine (2008)
  • "Dynamic contrast enhanced, MRI-guided trans-rectal biopsies in a closed 3 Tesla Scanner: Patient selection determines prostate cancer yield" ASCO Prostate Cancer Symposium, ASCO (2007)
  • "Concurrent 95 Gray IMRT Boost of Biopsy Proven, MRI Defined Dominant Intra-prostatic Lesions: Early Results of a Phase I NCI Study" ASTRO, ASTRO (2007)
  • "Imaging Individualization of Therapy & Rational Clinical Trial Design" Grand Rounds of the Eli Lilly Corporation, Eli Lilly Corporation (2007)
  • "Recent NCI Trials in Prostate Cancer: Radioproectors, MR Imaging, and Dose Escalation" , University of Nebraska (2007)
  • "Current and Future Prostate Imaging: Opportunities for Research & Rational Clinical Trial Designs" Center for Prostate Disease Research, Center for Prostate Disease Research (2006)
  • "Integration of MR Imaging into Radiation Oncology" , Washington University (2006)
  • "Optimization of Imaging for Target Volume Specification and Assessment" ASTRO Annual Mtg., ASTRO, Invited panelist (2006)
  • "Imaging, Individualization of Therapy & Rational Clinical Trial Design" , University of Arkansas for Medical Sciences (2006)
  • "Current Standards, Future Directions, and current NCI Clinical Research In Radiation Therapy for Prostate Cancer" NCI Symposium for Practicing Physicians: Focus on Prostate Cancer, National Cancer Institute (2006)
  • "Definition of Target Volumes, Imaging, & Opportunities For Clinical Research" Fourth Annual NCI-RRP Young Investigators Workshop, National Cancer Institute (2005)
  • "Concurrent Chemoradiation & Salvage of Isolated Para-aortic Lymph Node Recurrences" ASTRO Annual Mtg., ASTRO (2004)
  • "Review of Latest Developments in GI Cancers" ASTRO 2003 Review Course, Washington University, Eric P. Newman Center (2003)
  • "IMRT, PET, and Cervical Carcinoma" , National Cancer Institute, Department of Radiation Oncology (2003)
  • "Novel Imaging Methods for Assessment of Organ Motion and Target Delineation" , University of Florida, Department of Radiation Oncology (2003)
  • "Irradiation Dose, Lymph Node Size, and Tumor Control in Carcinoma of the Cervix" ASTRO Annual Mtg.- Poster Discussion, ASTRO (2003)
  • "Imaging Tumor Hypoxia In Vivo. Section WN BB4: Physiological Effects of Hyperthermia on Tumors and Normal Tissues" First International Congress on Stress Responses in Biology and Medicine (2003)
  • "Monitoring the Effect of 41 degree C Hyperthermia on Tumor Hypoxia by Cu-ATSM PET Scanning. Section WN BB2: Molecular Changes to Improve Clinical Responses" First International Congress on Stress Responses in Biology and Medicine (2003)
  • "FDG-PET Lymph Node Staging: Implications for the Treatment of Cervical Carcinoma." , University of Maryland, Department of Radiation Oncology (2003)
  • "FDG-PET Lymph Node Staging and Survival of Patients with FIGO Stage IIIB Cervical Carcinoma" ASTRO Annual Mtg., ASTRO (2002)
  • "Analysis of Clinical and Dosimetric Predictors of Radiation-Induced Esophageal Toxicity in Patients with Non Small Cell Lung Cancer Treated With Three Dimensional Conformal Radiation Therapy" ASTRO Annual Mtg., ASTRO (2001)
  • "Outcome of Patients with Rectal Adenocarcinoma and Localized Pelvic Non Nodal Metastatic Foci" 85th Scientific Assembly of the Radiological Society of North America Mtg., Radiological Society of North America (1999)
See all (21 more)
Service Activities:
  • NIH Review grants from Program Announcement PAR10-169; National Institutes of Health (NIH) ZRG1 SBIB-X(57)R Special Emphasis Panel on Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations; Panel Member (2012–present)
  • Editorial Board Member; Editorial Board Member for World Journal of Clinical Oncology; Board Member (2010–present)
  • Manuscript Referee; Manuscript Referee for International Journal of Urology; Reviewer (2010–present)
  • Manuscript Referee; Manuscript Referee for Clinical Lung Cancer; Reviewer (2009–present)
  • Manuscript Referee; Manuscript Referee for American Family Physician; Reviewer (2009–present)
  • Manuscript Referee; Manuscript Referee for Journal of Urology; Reviewer (2009–present)
  • Radiation Therapy Oncology Group (RTOG) Membership Committee; Radiation Therapy Oncology Group (RTOG) Membership Committee; Member (2009–present)
  • Radiation Therapy Oncology Group (RTOG) Lung Cancer Steering Committee; Radiation Therapy Oncology Group (RTOG) Lung Cancer Steering Committee; Member (2008–2010)
  • Manuscript Referee; Manuscript Referee for Cancer Research; Reviewer (2008–present)
  • Radiation Therapy Oncology Group (RTOG) Full Member Prinicipal Investigator Committee; Radiation Therapy Oncology Group (RTOG) Full Member Prinicipal Investigator Committee; Member (2008–present)
  • ASTRO Gynecologic Abstract Reviewer; American Society of Therapeutic Radiation Oncology (ASTRO) Gynecologic Abstract Reviewer; Reviewer (2007–2009)
  • Manuscript Referee; Manuscript Referee for Radiation Oncology; Reviewer (2007–present)
  • Manuscript Referee; Manuscript Referee for Breast Cancer Research; Reviewer (2006–present)
  • NCI Panel on Advanced Technologies in Radiation Therapy; NCI Panel on Advanced Technologies in Radiation Therapy; Panel Member (2006–present)
  • Manuscript Referee; Manuscript Referee for International Journal of Radiation Oncology Biology Physics; Reviewer (2005–present)
  • Manuscript Referee; Manuscript Referee for Cancer; Reviewer (2005–present)
  • Manuscript Referee; Manuscript Referee for Clinical Cancer Research; Reviewer (2005–present)
  • Manuscript Referee; Manuscript Referee for American Journal of Clinical Oncology; Reviewer (2005–present)
  • Associate Guest Editor; Associate Guest Editor for Medical Physics; Editor (2004–present)
  • Manuscript Referee; Manuscript Referee for International Journal of Gynecological Cancer; Reviewer (2003–present)
  • AAPM Education of Physicians Subcommittee; AAPM Education of Physicians Subcommittee; Member (2002–2004)
  • ASTRO Refresher Course Committee; ASTRO Refresher Course Committee; Member (2002–2004)
  • ASTRO Education Committee; ASTRO Education Committee; Member (2002–2003)

School News:
In the Media:

Clinical Specialties:
Clinical Offices:
Insurance Accepted:


Contact Information

Roswell Park Cancer Institute
Dept. of Radiation Medicine
Elm and Carlton Streets
Buffalo, NY 14263
Phone: (716) 845-3218
Fax: (716) 845-8254
Email: as277@buffalo.edu


Log in to Update Your Profile